Physician profile
Jack Tharp
NPI 1134706765
$4,566.59
in general payments reported to CMS, 2019-2025
12 companies · $4,303 in 2025
The $4,303 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.19 · 2023: $167 · 2024: $83.61 · 2025: $4,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,300 · Travel and Lodging: $2,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,299.92 |
| Travel and Lodging | $2,253.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $2,039.89 | 2025 | |
| Boston Scientific Corporation | $1,251.86 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Medtronic, INC. | $348.35 | 2023-2025 | Vanta Adaptivestim, Intellis Adaptivestim, Synchromedii |
| Biotronik Nro, INC. | $230.89 | 2025 | Prospera |
| Stratus Medical, LLC | $190.27 | 2025 | Nimbus |
| Abbott Laboratories | $140.31 | 2025 | Eterna |
| Nalu Medical, INC. | $132.16 | 2025 | Nalu Neurostimulation System |
| Merck Sharp & Dohme LLC | $89.14 | 2022-2025 | Bridion |
| Averitas Pharma INC. | $78.38 | 2025 | Qutenza |
| Lundbeck LLC | $26.25 | 2025 | Vyepti |
| Eagle Pharmaceuticals, INC. | $22.72 | 2024 | |
| Solventum Corporation | $16.37 | 2024 | Bair Hugger |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Tharp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.